Financial statements Polkemic
Balance sheet data of POLKEMIC
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 84 723 822,98 | 83 343 277,14 | 84 511 570,61 | 91 832 737,96 | 90 229 729,59 | 102 737 689,68 |
| A. Fixed assets | 51 564 185,66 | 48 943 481,91 | 46 960 507,03 | 45 046 997,33 | 41 084 190,47 | 38 868 613,96 |
| B. Current assets | 33 159 637,32 | 34 399 795,23 | 37 551 063,58 | 46 785 740,63 | 49 145 539,12 | 63 869 075,72 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 84 723 822,98 | 83 343 277,14 | 84 511 570,61 | 91 832 737,96 | 90 229 729,59 | 102 737 689,68 |
| A. Equity | 48 491 908,10 | 49 889 285,93 | 57 327 606,45 | 63 382 323,57 | 68 982 276,16 | 82 075 623,63 |
| B. Liabilities and provisions for liabilities | 36 231 914,88 | 33 453 991,21 | 27 183 964,16 | 28 450 414,39 | 21 247 453,43 | 20 662 066,05 |
| I. Long-term liabilities | 6 590 598,57 | 6 715 612,15 | 7 386 920,27 | 4 616 238,95 | 3 110 078,49 | 2 124 798,61 |
| II. Short-term liabilities | 19 462 683,74 | 17 603 456,58 | 11 467 537,88 | 16 578 735,24 | 11 909 958,93 | 12 995 763,21 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.